established in 2000, brainsgate is a medical device company committed to developing innovative therapies for patients suffering from central nervous system (cns) diseases. brainsgate's platform technology involves electrical stimulation of the spheno-palatine ganglion (spg), a nervous center known to increase cerebral blood flow. brainsgate is exploring several applications for its technology, and is currently focusing on two directions: treatment of acute ischemic stroke, and delivering drugs into the central nervous system by increasing the permeability of the blood-brain barrier.
wesite:
